13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tertiary lymphoid structures in cancer and beyond.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Tertiary lymphoid structures (TLS) are ectopic lymphoid formations found in inflamed, infected, or tumoral tissues. They exhibit all the characteristics of structures in the lymph nodes (LN) associated with the generation of an adaptive immune response, including a T cell zone with mature dendritic cells (DC), a germinal center with follicular dendritic cells (FDC) and proliferating B cells, and high endothelial venules (HEV). In this review, we discuss evidence for the roles of TLS in chronic infection, autoimmunity, and cancer, and address the question of whether TLS present beneficial or deleterious effects in these contexts. We examine the relationship between TLS in tumors and patient prognosis, and discuss the potential role of TLS in building and/or maintaining local immune responses and how this understanding may guide therapeutic interventions.

          Related collections

          Author and article information

          Journal
          Trends Immunol.
          Trends in immunology
          1471-4981
          1471-4906
          Nov 2014
          : 35
          : 11
          Affiliations
          [1 ] Laboratory 'Cancer, Immune Control and Escape', INSERM U1138, Cordeliers Research Centre, Paris, France; University Pierre and Marie Curie, UMRS 1138, Paris, France; University Paris Descartes, UMRS 1138, Paris, France.
          [2 ] Laboratory 'Cancer, Immune Control and Escape', INSERM U1138, Cordeliers Research Centre, Paris, France; University Pierre and Marie Curie, UMRS 1138, Paris, France; University Paris Descartes, UMRS 1138, Paris, France. Electronic address: herve.fridman@crc.jussieu.fr.
          Article
          S1471-4906(14)00168-9
          10.1016/j.it.2014.09.006
          25443495
          b38bd3b6-0170-4fac-aa0a-5668228823cc
          Copyright © 2014 Elsevier Ltd. All rights reserved.
          History

          cancer,immunotherapy,prognostic biomarker,tertiary lymphoid structure

          Comments

          Comment on this article